Clinical Trial Update: Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB)

View source ↗

Summary

A pediatric study evaluating botulinum toxin type A for non-neurogenic, therapy-resistant overactive bladder has completed; the trial is sponsored by the Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: University of Aarhus | Conditions: Overactive Bladder, Incontinence, Daytime Urinary | Status: COMPLETED